These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 12766880

  • 1. Posttransplant day significantly influences pharmacokinetics of cyclosporine after hematopoietic stem cell transplantation.
    Jacobson PA, Ng J, Green KG, Rogosheske J, Brundage R.
    Biol Blood Marrow Transplant; 2003 May; 9(5):304-11. PubMed ID: 12766880
    [Abstract] [Full Text] [Related]

  • 2. Population pharmacokinetics of ciclosporin in haematopoietic allogeneic stem cell transplantation with emphasis on limited sampling strategy.
    Wilhelm AJ, de Graaf P, Veldkamp AI, Janssen JJ, Huijgens PC, Swart EL.
    Br J Clin Pharmacol; 2012 Apr; 73(4):553-63. PubMed ID: 21988410
    [Abstract] [Full Text] [Related]

  • 3. Population pharmacokinetic study of cyclosporine in the hematopoietic stem cell transplant recipients.
    Zhou Y, Sheng XY, Xu JY, Bi SS, Lu W, Cui YM.
    Int J Clin Pharmacol Ther; 2013 Jul; 51(7):568-75. PubMed ID: 23611568
    [Abstract] [Full Text] [Related]

  • 4. Factors affecting the pharmacokinetics of tacrolimus (FK506) in hematopoietic cell transplant (HCT) patients.
    Jacobson P, Ng J, Ratanatharathorn V, Uberti J, Brundage RC.
    Bone Marrow Transplant; 2001 Oct; 28(8):753-8. PubMed ID: 11781626
    [Abstract] [Full Text] [Related]

  • 5. Population pharmacokinetics and Bayesian estimation of cyclosporine in a Tunisian population of hematopoietic stem cell transplant recipient.
    Eljebari H, Gaies E, Fradj NB, Jebabli N, Salouage I, Trabelsi S, Lakhal M, Klouz A.
    Eur J Clin Pharmacol; 2012 Nov; 68(11):1517-24. PubMed ID: 22527344
    [Abstract] [Full Text] [Related]

  • 6. ABCB1 C3435T genetic polymorphism on population pharmacokinetics of methotrexate after hematopoietic stem cell transplantation in Korean patients: a prospective analysis.
    Kim IW, Yun HY, Choi B, Han N, Park SY, Lee ES, Oh JM.
    Clin Ther; 2012 Aug; 34(8):1816-26. PubMed ID: 22796246
    [Abstract] [Full Text] [Related]

  • 7. Population pharmacokinetics of cyclosporine in hematopoietic stem cell transplant patients: consideration of genetic polymorphisms.
    Kim MG, Kim IW, Choi B, Han N, Yun HY, Park S, Oh JM.
    Ann Pharmacother; 2015 Jun; 49(6):622-30. PubMed ID: 25818517
    [Abstract] [Full Text] [Related]

  • 8. Population pharmacokinetics of cyclosporine in Chinese children receiving hematopoietic stem cell transplantation.
    Li TF, Hu L, Ma XL, Huang L, Liu XM, Luo XX, Feng WY, Wu CF.
    Acta Pharmacol Sin; 2019 Dec; 40(12):1603-1610. PubMed ID: 31341257
    [Abstract] [Full Text] [Related]

  • 9. Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation.
    Canadian Neoral Renal Transplantation Study Group.
    Transplantation; 2001 Sep 27; 72(6):1024-32. PubMed ID: 11579295
    [Abstract] [Full Text] [Related]

  • 10. Population pharmacokinetics and individualized dosage prediction of cyclosporine in allogeneic hematopoietic stem cell transplant patients.
    Xue L, Zhang WW, Ding XL, Zhang JJ, Bao JA, Miao LY.
    Am J Med Sci; 2014 Dec 27; 348(6):448-54. PubMed ID: 25247760
    [Abstract] [Full Text] [Related]

  • 11. Prediction of area under the cyclosporine concentration versus time curve in children undergoing hematopoietic stem cell transplantation.
    Dupuis LL, Seto W, Teuffel O, Gibson P, Schultz KR, Doyle JD, Gassas A, Egeler RM, Sung L, Schechter T.
    Biol Blood Marrow Transplant; 2013 Mar 27; 19(3):418-23. PubMed ID: 23128321
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of cyclosporine a conversion from twice-daily infusion to oral administration in allogeneic hematopoietic stem cell transplantation.
    Inoue Y, Saito T, Ogawa K, Nishio Y, Kosugi S, Suzuki Y, Kato M, Sakai H, Takahashi M, Miura I.
    Am J Ther; 2014 Mar 27; 21(5):377-84. PubMed ID: 23011175
    [Abstract] [Full Text] [Related]

  • 14. Population pharmacokinetics of cyclosporine in cardiopulmonary transplant recipients.
    Rosenbaum SE, Baheti G, Trull AK, Akhlaghi F.
    Ther Drug Monit; 2005 Apr 27; 27(2):116-22. PubMed ID: 15795639
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Initial dosage optimisation of cyclosporine in Chinese paediatric patients undergoing allogeneic haematopoietic stem cell transplantation based on population pharmacokinetics: a retrospective study.
    Feng H, Wang X, Zheng W, Liu S, Jiang H, Lin Y, Qiu H, Chan TF, Huang M, Li Y, Mo X, Li J.
    BMJ Paediatr Open; 2023 Aug 27; 7(1):. PubMed ID: 37643815
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evaluation of safety and pharmacokinetics of administering intravenous busulfan in a twice-daily or daily schedule to patients with advanced hematologic malignant disease undergoing stem cell transplantation.
    Fernandez HF, Tran HT, Albrecht F, Lennon S, Caldera H, Goodman MS.
    Biol Blood Marrow Transplant; 2002 Aug 27; 8(9):486-92. PubMed ID: 12374453
    [Abstract] [Full Text] [Related]

  • 20. Population pharmacokinetics of ciclosporin in allogeneic hematopoietic stem cell transplant recipients: C-reactive protein as a novel covariate for clearance.
    Ling J, Yang XP, Dong LL, Jiang Y, Zou SL, Hu N, Chen R.
    J Clin Pharm Ther; 2022 Apr 27; 47(4):483-492. PubMed ID: 34779003
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.